The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Active Pharmaceutical Ingredients (API) Market Outlook 2024
Synopsis
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson & Johnson are the top 5 manufacturers of industry.
Market Analysis and Insights: Global Active Pharmaceutical Ingredients (API) Market
The global Active Pharmaceutical Ingredients (API) market was valued at US$ 67700 million in 2020 and it is expected to reach US$ 105780 million by the end of 2027, growing at a CAGR of 6.6% during 2021-2027.
Global Active Pharmaceutical Ingredients (API) Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Active Pharmaceutical Ingredients (API) Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Synthetic APIs
Biotech APIs
Segment by Application
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
By Company
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Production by Region
North America
Europe
China
Japan
India
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
India is the largest region of Active Pharmaceutical Ingredients (API), with a market share about 30%. Teva Active Pharmaceutical Industries Limited, DSM, Novartis, Roche and Johnson & Johnson are the top 5 manufacturers of industry.
Market Analysis and Insights: Global Active Pharmaceutical Ingredients (API) Market
The global Active Pharmaceutical Ingredients (API) market was valued at US$ 67700 million in 2020 and it is expected to reach US$ 105780 million by the end of 2027, growing at a CAGR of 6.6% during 2021-2027.
Global Active Pharmaceutical Ingredients (API) Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Active Pharmaceutical Ingredients (API) Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Synthetic APIs
Biotech APIs
Segment by Application
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others
By Company
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
Production by Region
North America
Europe
China
Japan
India
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Index1 Active Pharmaceutical Ingredients (API) Market Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients (API)
1.2 Active Pharmaceutical Ingredients (API) Segment by Type
1.2.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate Analysis by Type 2021 VS 2027
1.2.2 Synthetic APIs
1.2.3 Biotech APIs
1.3 Active Pharmaceutical Ingredients (API) Segment by Application
1.3.1 Global Active Pharmaceutical Ingredients (API) Consumption Comparison by Application: 2016 VS 2021 VS 2027
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Global Market Growth Prospects
1.4.1 Global Active Pharmaceutical Ingredients (API) Revenue Estimates and Forecasts (2016-2027)
1.4.2 Global Active Pharmaceutical Ingredients (API) Production Capacity Estimates and Forecasts (2016-2027)
1.4.3 Global Active Pharmaceutical Ingredients (API) Production Estimates and Forecasts (2016-2027)
1.5 Global Market Size by Region
1.5.1 Global Active Pharmaceutical Ingredients (API) Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
1.5.2 North America Active Pharmaceutical Ingredients (API) Estimates and Forecasts (2016-2027)
1.5.3 Europe Active Pharmaceutical Ingredients (API) Estimates and Forecasts (2016-2027)
1.5.4 China Active Pharmaceutical Ingredients (API) Estimates and Forecasts (2016-2027)
1.5.5 Japan Active Pharmaceutical Ingredients (API) Estimates and Forecasts (2016-2027)
1.5.6 India Active Pharmaceutical Ingredients (API) Estimates and Forecasts (2016-2027)
2 Market Competition by Manufacturers
2.1 Global Active Pharmaceutical Ingredients (API) Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturers (2016-2021)
2.3 Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2016-2021)
2.5 Manufacturers Active Pharmaceutical Ingredients (API) Production Sites, Area Served, Product Types
2.6 Active Pharmaceutical Ingredients (API) Market Competitive Situation and Trends
2.6.1 Active Pharmaceutical Ingredients (API) Market Concentration Rate
2.6.2 Global 5 and 10 Largest Active Pharmaceutical Ingredients (API) Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production and Capacity by Region
3.1 Global Production Capacity of Active Pharmaceutical Ingredients (API) Market Share by Region (2016-2021)
3.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2016-2021)
3.3 Global Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 North America Active Pharmaceutical Ingredients (API) Production
3.4.1 North America Active Pharmaceutical Ingredients (API) Production Growth Rate (2016-2021)
3.4.2 North America Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Active Pharmaceutical Ingredients (API) Production
3.5.1 Europe Active Pharmaceutical Ingredients (API) Production Growth Rate (2016-2021)
3.5.2 Europe Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 China Active Pharmaceutical Ingredients (API) Production
3.6.1 China Active Pharmaceutical Ingredients (API) Production Growth Rate (2016-2021)
3.6.2 China Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Japan Active Pharmaceutical Ingredients (API) Production
3.7.1 Japan Active Pharmaceutical Ingredients (API) Production Growth Rate (2016-2021)
3.7.2 Japan Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 India Active Pharmaceutical Ingredients (API) Production
3.8.1 India Active Pharmaceutical Ingredients (API) Production Growth Rate (2016-2021)
3.8.2 India Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
4 Global Active Pharmaceutical Ingredients (API) Consumption by Region
4.1 Global Active Pharmaceutical Ingredients (API) Consumption by Region
4.1.1 Global Active Pharmaceutical Ingredients (API) Consumption by Region
4.1.2 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Region
4.2 North America
4.2.1 North America Active Pharmaceutical Ingredients (API) Consumption by Country
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Active Pharmaceutical Ingredients (API) Consumption by Country
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Active Pharmaceutical Ingredients (API) Consumption by Country
4.5.2 Mexico
4.5.3 Brazil
5 Production, Revenue, Price Trend by Type
5.1 Global Active Pharmaceutical Ingredients (API) Production Market Share by Type (2016-2021)
5.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2016-2021)
5.3 Global Active Pharmaceutical Ingredients (API) Price by Type (2016-2021)
6 Consumption Analysis by Application
6.1 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2016-2021)
6.2 Global Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Application (2016-2021)
7 Key Companies Profiled
7.1 Teva
7.1.1 Teva Active Pharmaceutical Ingredients (API) Corporation Information
7.1.2 Teva Active Pharmaceutical Ingredients (API) Product Portfolio
7.1.3 Teva Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.1.4 Teva Main Business and Markets Served
7.1.5 Teva Recent Developments/Updates
7.2 Mylan
7.2.1 Mylan Active Pharmaceutical Ingredients (API) Corporation Information
7.2.2 Mylan Active Pharmaceutical Ingredients (API) Product Portfolio
7.2.3 Mylan Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.2.4 Mylan Main Business and Markets Served
7.2.5 Mylan Recent Developments/Updates
7.3 DSM
7.3.1 DSM Active Pharmaceutical Ingredients (API) Corporation Information
7.3.2 DSM Active Pharmaceutical Ingredients (API) Product Portfolio
7.3.3 DSM Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.3.4 DSM Main Business and Markets Served
7.3.5 DSM Recent Developments/Updates
7.4 Aurobindo Pharma
7.4.1 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Corporation Information
7.4.2 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product Portfolio
7.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.4.4 Aurobindo Pharma Main Business and Markets Served
7.4.5 Aurobindo Pharma Recent Developments/Updates
7.5 Aspen
7.5.1 Aspen Active Pharmaceutical Ingredients (API) Corporation Information
7.5.2 Aspen Active Pharmaceutical Ingredients (API) Product Portfolio
7.5.3 Aspen Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.5.4 Aspen Main Business and Markets Served
7.5.5 Aspen Recent Developments/Updates
7.6 Novartis
7.6.1 Novartis Active Pharmaceutical Ingredients (API) Corporation Information
7.6.2 Novartis Active Pharmaceutical Ingredients (API) Product Portfolio
7.6.3 Novartis Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.6.4 Novartis Main Business and Markets Served
7.6.5 Novartis Recent Developments/Updates
7.7 BASF
7.7.1 BASF Active Pharmaceutical Ingredients (API) Corporation Information
7.7.2 BASF Active Pharmaceutical Ingredients (API) Product Portfolio
7.7.3 BASF Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.7.4 BASF Main Business and Markets Served
7.7.5 BASF Recent Developments/Updates
7.8 Pfizer
7.8.1 Pfizer Active Pharmaceutical Ingredients (API) Corporation Information
7.8.2 Pfizer Active Pharmaceutical Ingredients (API) Product Portfolio
7.8.3 Pfizer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.8.4 Pfizer Main Business and Markets Served
7.7.5 Pfizer Recent Developments/Updates
7.9 Huahai Pharmaceutical
7.9.1 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Corporation Information
7.9.2 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
7.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.9.4 Huahai Pharmaceutical Main Business and Markets Served
7.9.5 Huahai Pharmaceutical Recent Developments/Updates
7.10 Hisun Pharmaceutical
7.10.1 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Corporation Information
7.10.2 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
7.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.10.4 Hisun Pharmaceutical Main Business and Markets Served
7.10.5 Hisun Pharmaceutical Recent Developments/Updates
7.11 Sun Pharmaceutical Industries
7.11.1 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Corporation Information
7.11.2 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product Portfolio
7.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.11.4 Sun Pharmaceutical Industries Main Business and Markets Served
7.11.5 Sun Pharmaceutical Industries Recent Developments/Updates
7.12 Zhejiang Medicine
7.12.1 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Corporation Information
7.12.2 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product Portfolio
7.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.12.4 Zhejiang Medicine Main Business and Markets Served
7.12.5 Zhejiang Medicine Recent Developments/Updates
7.13 Dr. Reddy’s Laboratories
7.13.1 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Corporation Information
7.13.2 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product Portfolio
7.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.13.4 Dr. Reddy’s Laboratories Main Business and Markets Served
7.13.5 Dr. Reddy’s Laboratories Recent Developments/Updates
7.14 Zhejiang NHU
7.14.1 Zhejiang NHU Active Pharmaceutical Ingredients (API) Corporation Information
7.14.2 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product Portfolio
7.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.14.4 Zhejiang NHU Main Business and Markets Served
7.14.5 Zhejiang NHU Recent Developments/Updates
7.15 Bayer
7.15.1 Bayer Active Pharmaceutical Ingredients (API) Corporation Information
7.15.2 Bayer Active Pharmaceutical Ingredients (API) Product Portfolio
7.15.3 Bayer Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.15.4 Bayer Main Business and Markets Served
7.15.5 Bayer Recent Developments/Updates
7.16 NCPC
7.16.1 NCPC Active Pharmaceutical Ingredients (API) Corporation Information
7.16.2 NCPC Active Pharmaceutical Ingredients (API) Product Portfolio
7.16.3 NCPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.16.4 NCPC Main Business and Markets Served
7.16.5 NCPC Recent Developments/Updates
7.17 AbbVie
7.17.1 AbbVie Active Pharmaceutical Ingredients (API) Corporation Information
7.17.2 AbbVie Active Pharmaceutical Ingredients (API) Product Portfolio
7.17.3 AbbVie Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.17.4 AbbVie Main Business and Markets Served
7.17.5 AbbVie Recent Developments/Updates
7.18 Shandong Xinhua Pharmaceutical
7.18.1 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Corporation Information
7.18.2 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
7.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.18.4 Shandong Xinhua Pharmaceutical Main Business and Markets Served
7.18.5 Shandong Xinhua Pharmaceutical Recent Developments/Updates
7.19 Northeast Pharm
7.19.1 Northeast Pharm Active Pharmaceutical Ingredients (API) Corporation Information
7.19.2 Northeast Pharm Active Pharmaceutical Ingredients (API) Product Portfolio
7.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.19.4 Northeast Pharm Main Business and Markets Served
7.19.5 Northeast Pharm Recent Developments/Updates
7.20 Harbin Pharmaceutical
7.20.1 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Corporation Information
7.20.2 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product Portfolio
7.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.20.4 Harbin Pharmaceutical Main Business and Markets Served
7.20.5 Harbin Pharmaceutical Recent Developments/Updates
7.21 LKPC
7.21.1 LKPC Active Pharmaceutical Ingredients (API) Corporation Information
7.21.2 LKPC Active Pharmaceutical Ingredients (API) Product Portfolio
7.21.3 LKPC Active Pharmaceutical Ingredients (API) Production Capacity, Revenue, Price and Gross Margin (2016-2021)
7.21.4 LKPC Main Business and Markets Served
7.21.5 LKPC Recent Developments/Updates
8 Active Pharmaceutical Ingredients (API) Manufacturing Cost Analysis
8.1 Active Pharmaceutical Ingredients (API) Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
8.4 Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Active Pharmaceutical Ingredients (API) Distributors List
9.3 Active Pharmaceutical Ingredients (API) Customers
10 Market Dynamics
10.1 Active Pharmaceutical Ingredients (API) Industry Trends
10.2 Active Pharmaceutical Ingredients (API) Growth Drivers
10.3 Active Pharmaceutical Ingredients (API) Market Challenges
10.4 Active Pharmaceutical Ingredients (API) Market Restraints
11 Production and Supply Forecast
11.1 Global Forecasted Production of Active Pharmaceutical Ingredients (API) by Region (2022-2027)
11.2 North America Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
11.3 Europe Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
11.4 China Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
11.5 Japan Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
11.6 India Active Pharmaceutical Ingredients (API) Production, Revenue Forecast (2022-2027)
12 Consumption and Demand Forecast
12.1 Global Forecasted Demand Analysis of Active Pharmaceutical Ingredients (API)
12.2 North America Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
12.3 Europe Market Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
12.4 Asia Pacific Market Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Region
12.5 Latin America Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Country
13 Forecast by Type and by Application (2022-2027)
13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
13.1.1 Global Forecasted Production of Active Pharmaceutical Ingredients (API) by Type (2022-2027)
13.1.2 Global Forecasted Revenue of Active Pharmaceutical Ingredients (API) by Type (2022-2027)
13.1.3 Global Forecasted Price of Active Pharmaceutical Ingredients (API) by Type (2022-2027)
13.2 Global Forecasted Consumption of Active Pharmaceutical Ingredients (API) by Application (2022-2027)
14 Research Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of TablesList of Tables
Table 1. Global Active Pharmaceutical Ingredients (API) Market Size by Type (Tons) & (US$ Million) (2021 VS 2027)
Table 2. Global Active Pharmaceutical Ingredients (API) Consumption (Tons) Comparison by Application: 2016 VS 2021 VS 2027
Table 3. Active Pharmaceutical Ingredients (API) Market Size Comparison by Region: 2016 VS 2021 VS 2027
Table 4. Global Active Pharmaceutical Ingredients (API) Production Capacity (Tons) by Manufacturers
Table 5. Global Active Pharmaceutical Ingredients (API) Production (Tons) by Manufacturers (2016-2021)
Table 6. Global Active Pharmaceutical Ingredients (API) Production Market Share by Manufacturers (2016-2021)
Table 7. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2016-2021)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients (API) as of 2020)
Table 10. Global Market Active Pharmaceutical Ingredients (API) Average Price (USD/Ton) of Key Manufacturers (2016-2021)
Table 11. Manufacturers Active Pharmaceutical Ingredients (API) Production Sites and Area Served
Table 12. Manufacturers Active Pharmaceutical Ingredients (API) Product Types
Table 13. Mergers & Acquisitions, Expansion
Table 14. Global Active Pharmaceutical Ingredients (API) Production Capacity (Tons) by Region (2016-2021)
Table 15. Global Active Pharmaceutical Ingredients (API) Production (Tons) by Region (2016-2021)
Table 16. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Region (2016-2021)
Table 17. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2016-2021)
Table 18. Global Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 19. North America Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 20. Europe Active Pharmaceutical Ingredients (API) Production (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 21. China Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 22. Japan Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 23. India Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 24. Global Active Pharmaceutical Ingredients (API) Consumption Market by Region (2016-2021) & (Tons)
Table 25. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Region (2016-2021)
Table 26. North America Active Pharmaceutical Ingredients (API) Consumption by Country (2016-2021) & (Tons)
Table 27. Europe Active Pharmaceutical Ingredients (API) Consumption by Country (2016-2021) & (Tons)
Table 28. Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Region (2016-2021) & (Tons)
Table 29. Latin America Active Pharmaceutical Ingredients (API) Consumption by Countries (2016-2021) & (Tons)
Table 30. Global Active Pharmaceutical Ingredients (API) Production (Tons) by Type (2016-2021)
Table 31. Global Active Pharmaceutical Ingredients (API) Production Market Share by Type (2016-2021)
Table 32. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) by Type (2016-2021)
Table 33. Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2016-2021)
Table 34. Global Active Pharmaceutical Ingredients (API) Price (USD/Ton) by Type (2016-2021)
Table 35. Global Active Pharmaceutical Ingredients (API) Consumption by Application (2016-2021) & (Tons)
Table 36. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2016-2021)
Table 37. Global Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Application (2016-2021)
Table 38. Teva Active Pharmaceutical Ingredients (API) Corporation Information
Table 39. Teva Specification and Application
Table 40. Teva Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 41. Teva Main Business and Markets Served
Table 42. Teva Recent Developments/Updates
Table 43. Mylan Active Pharmaceutical Ingredients (API) Corporation Information
Table 44. Mylan Specification and Application
Table 45. Mylan Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 46. Mylan Main Business and Markets Served
Table 47. Mylan Recent Developments/Updates
Table 48. DSM Active Pharmaceutical Ingredients (API) Corporation Information
Table 49. DSM Specification and Application
Table 50. DSM Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 51. DSM Main Business and Markets Served
Table 52. DSM Recent Developments/Updates
Table 53. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Corporation Information
Table 54. Aurobindo Pharma Specification and Application
Table 55. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 56. Aurobindo Pharma Main Business and Markets Served
Table 57. Aurobindo Pharma Recent Developments/Updates
Table 58. Aspen Active Pharmaceutical Ingredients (API) Corporation Information
Table 59. Aspen Specification and Application
Table 60. Aspen Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 61. Aspen Main Business and Markets Served
Table 62. Aspen Recent Developments/Updates
Table 63. Novartis Active Pharmaceutical Ingredients (API) Corporation Information
Table 64. Novartis Specification and Application
Table 65. Novartis Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 66. Novartis Main Business and Markets Served
Table 67. Novartis Recent Developments/Updates
Table 68. BASF Active Pharmaceutical Ingredients (API) Corporation Information
Table 69. BASF Specification and Application
Table 70. BASF Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 71. BASF Main Business and Markets Served
Table 72. BASF Recent Developments/Updates
Table 73. Pfizer Active Pharmaceutical Ingredients (API) Corporation Information
Table 74. Pfizer Specification and Application
Table 75. Pfizer Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 76. Pfizer Main Business and Markets Served
Table 77. Pfizer Recent Developments/Updates
Table 78. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Corporation Information
Table 79. Huahai Pharmaceutical Specification and Application
Table 80. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 81. Huahai Pharmaceutical Main Business and Markets Served
Table 82. Huahai Pharmaceutical Recent Developments/Updates
Table 83. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Corporation Information
Table 84. Hisun Pharmaceutical Specification and Application
Table 85. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 86. Hisun Pharmaceutical Main Business and Markets Served
Table 87. Hisun Pharmaceutical Recent Developments/Updates
Table 88. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Corporation Information
Table 89. Sun Pharmaceutical Industries Specification and Application
Table 90. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 91. Sun Pharmaceutical Industries Main Business and Markets Served
Table 92. Sun Pharmaceutical Industries Recent Developments/Updates
Table 93. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Corporation Information
Table 94. Zhejiang Medicine Specification and Application
Table 95. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 96. Zhejiang Medicine Main Business and Markets Served
Table 97. Zhejiang Medicine Recent Developments/Updates
Table 98. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Corporation Information
Table 99. Dr. Reddy’s Laboratories Specification and Application
Table 100. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 101. Dr. Reddy’s Laboratories Main Business and Markets Served
Table 102. Dr. Reddy’s Laboratories Recent Developments/Updates
Table 103. Zhejiang NHU Active Pharmaceutical Ingredients (API) Corporation Information
Table 104. Zhejiang NHU Specification and Application
Table 105. Zhejiang NHU Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 106. Zhejiang NHU Main Business and Markets Served
Table 107. Zhejiang NHU Recent Developments/Updates
Table 108. Zhejiang NHU Active Pharmaceutical Ingredients (API) Corporation Information
Table 109. Bayer Specification and Application
Table 110. Bayer Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 111. Bayer Main Business and Markets Served
Table 112. Bayer Recent Developments/Updates
Table 113. NCPC Active Pharmaceutical Ingredients (API) Corporation Information
Table 114. NCPC Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 115. NCPC Main Business and Markets Served
Table 116. NCPC Recent Developments/Updates
Table 117. AbbVie Active Pharmaceutical Ingredients (API) Corporation Information
Table 118. AbbVie Specification and Application
Table 119. AbbVie Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 120. AbbVie Main Business and Markets Served
Table 121. AbbVie Recent Developments/Updates
Table 122. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Corporation Information
Table 123. Shandong Xinhua Pharmaceutical Specification and Application
Table 124. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 125. Shandong Xinhua Pharmaceutical Main Business and Markets Served
Table 126. Shandong Xinhua Pharmaceutical Recent Developments/Updates
Table 127. Northeast Pharm Active Pharmaceutical Ingredients (API) Corporation Information
Table 128. Northeast Pharm Specification and Application
Table 129. Northeast Pharm Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 130. Northeast Pharm Main Business and Markets Served
Table 131. Northeast Pharm Recent Developments/Updates
Table 132. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Corporation Information
Table 133. Harbin Pharmaceutical Specification and Application
Table 134. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 135. Harbin Pharmaceutical Main Business and Markets Served
Table 136. Harbin Pharmaceutical Recent Developments/Updates
Table 137. LKPC Active Pharmaceutical Ingredients (API) Corporation Information
Table 138. LKPC Specification and Application
Table 139. LKPC Active Pharmaceutical Ingredients (API) Production Capacity (Tons), Revenue (US$ Million), Price (USD/Ton) and Gross Margin (2016-2021)
Table 140. LKPC Main Business and Markets Served
Table 141. LKPC Recent Developments/Updates
Table 142. Production Base and Market Concentration Rate of Raw Material
Table 143. Key Suppliers of Raw Materials
Table 144. Active Pharmaceutical Ingredients (API) Distributors List
Table 145. Active Pharmaceutical Ingredients (API) Customers List
Table 146. Active Pharmaceutical Ingredients (API) Market Trends
Table 147. Active Pharmaceutical Ingredients (API) Growth Drivers
Table 148. Active Pharmaceutical Ingredients (API) Market Challenges
Table 149. Active Pharmaceutical Ingredients (API) Market Restraints
Table 150. Global Active Pharmaceutical Ingredients (API) Production (Tons) Forecast by Region (2022-2027)
Table 151. North America Active Pharmaceutical Ingredients (API) Consumption Forecast by Country (2022-2027) & (Tons)
Table 152. Europe Active Pharmaceutical Ingredients (API) Consumption Forecast by Country (2022-2027) & (Tons)
Table 153. Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Forecast by Region (2022-2027) & (Tons)
Table 154. Latin America Active Pharmaceutical Ingredients (API) Consumption Forecast by Country (2022-2027) & (Tons)
Table 155. Global Active Pharmaceutical Ingredients (API) Production Forecast by Type (2022-2027) & (Tons)
Table 156. Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 157. Global Active Pharmaceutical Ingredients (API) Price Forecast by Type (2022-2027) & (USD/Ton)
Table 158. Global Active Pharmaceutical Ingredients (API) Consumption (Tons) Forecast by Application (2022-2027)
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Active Pharmaceutical Ingredients (API)
Figure 2. Global Active Pharmaceutical Ingredients (API) Market Share by Type: 2020 VS 2027
Figure 3. Synthetic APIs Product Picture
Figure 4. Biotech APIs Product Picture
Figure 5. Global Active Pharmaceutical Ingredients (API) Market Share by Application: 2020 VS 2027
Figure 6. CNS
Figure 7. Cardiovascular
Figure 8. Genitourinary/Hormonal Drugs
Figure 9. Respiratory
Figure 10. Rheumatology
Figure 11. Diabetes
Figure 12. Oncology
Figure 13. Others
Figure 14. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Active Pharmaceutical Ingredients (API) Revenue (US$ Million) (2016-2027)
Figure 16. Global Active Pharmaceutical Ingredients (API) Production Capacity (Tons) & (2016-2027)
Figure 17. Global Active Pharmaceutical Ingredients (API) Production (Tons) & (2016-2027)
Figure 18. North America Active Pharmaceutical Ingredients (API) Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 19. Europe Active Pharmaceutical Ingredients (API) Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 20. China Active Pharmaceutical Ingredients (API) Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 21. Japan Active Pharmaceutical Ingredients (API) Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 22. India Active Pharmaceutical Ingredients (API) Revenue (US$ Million) and Growth Rate (2016-2027)
Figure 23. Active Pharmaceutical Ingredients (API) Production Share by Manufacturers in 2020
Figure 24. Global Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers in 2020
Figure 25. Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Market Active Pharmaceutical Ingredients (API) Average Price (USD/Ton) of Key Manufacturers in 2020
Figure 27. The Global 5 and 10 Largest Players: Market Share by Active Pharmaceutical Ingredients (API) Revenue in 2020
Figure 28. Global Active Pharmaceutical Ingredients (API) Production Market Share by Region (2016-2021)
Figure 29. North America Active Pharmaceutical Ingredients (API) Production (Tons) Growth Rate (2016-2021)
Figure 30. Europe Active Pharmaceutical Ingredients (API) Production (Tons) Growth Rate (2016-2021)
Figure 31. China Active Pharmaceutical Ingredients (API) Production (Tons) Growth Rate (2016-2021)
Figure 32. Japan Active Pharmaceutical Ingredients (API) Production (Tons) Growth Rate (2016-2021)
Figure 33. India Active Pharmaceutical Ingredients (API) Production (Tons) Growth Rate (2016-2021)
Figure 34. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Region (2016-2021)
Figure 35. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Region in 2020
Figure 36. North America Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 37. North America Active Pharmaceutical Ingredients (API) Consumption Market Share by Country in 2020
Figure 38. Canada Active Pharmaceutical Ingredients (API) Consumption Growth Rate (2016-2021) & (Tons)
Figure 39. U.S. Active Pharmaceutical Ingredients (API) Consumption Growth Rate (2016-2021) & (Tons)
Figure 40. Europe Active Pharmaceutical Ingredients (API) Consumption Growth Rate (2016-2021) & (Tons)
Figure 41. Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Country in 2020
Figure 42. Germany America Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 43. France Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 44. U.K. Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 45. Italy Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 46. Russia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 47. Asia Pacific Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 48. Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Market Share by Regions in 2020
Figure 49. China Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 50. Japan Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 51. South Korea Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 52. Taiwan Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 53. Southeast Asia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 54. India Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 55. Australia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 56. Latin America Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 57. Latin America Active Pharmaceutical Ingredients (API) Consumption Market Share by Country in 2020
Figure 58. Mexico Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 59. Brazil Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2016-2021) & (Tons)
Figure 60. Production Market Share of Active Pharmaceutical Ingredients (API) by Type (2016-2021)
Figure 61. Production Market Share of Active Pharmaceutical Ingredients (API) by Type in 2020
Figure 62. Revenue Share of Active Pharmaceutical Ingredients (API) by Type (2016-2021)
Figure 63. Revenue Market Share of Active Pharmaceutical Ingredients (API) by Type in 2020
Figure 64. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2016-2021)
Figure 65. Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application in 2020
Figure 66. Global Active Pharmaceutical Ingredients (API) Consumption Growth Rate by Application (2016-2021)
Figure 67. Key Raw Materials Price Trend
Figure 68. Manufacturing Cost Structure of Active Pharmaceutical Ingredients (API)
Figure 69. Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)
Figure 70. Active Pharmaceutical Ingredients (API) Industrial Chain Analysis
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 73. Global Active Pharmaceutical Ingredients (API) Production Market Share Forecast by Region (2022-2027)
Figure 74. North America Active Pharmaceutical Ingredients (API) Production (Tons) Growth Rate Forecast (2022-2027)
Figure 75. Europe Active Pharmaceutical Ingredients (API) Production (Tons) Growth Rate Forecast (2022-2027)
Figure 76. China Active Pharmaceutical Ingredients (API) Production (Tons) Growth Rate Forecast (2022-2027)
Figure 77. Japan Active Pharmaceutical Ingredients (API) Production (Tons) Growth Rate Forecast (2022-2027)
Figure 78. India Active Pharmaceutical Ingredients (API) Production (Tons) Growth Rate Forecast (2022-2027)
Figure 79. Global Forecasted Demand Analysis of Active Pharmaceutical Ingredients (API) (2015-2027) & (Tons)
Figure 80. Global Active Pharmaceutical Ingredients (API) Production Market Share Forecast by Type (2022-2027)
Figure 81. Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Type (2022-2027)
Figure 82. Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Application (2022-2027)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
